These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22370270)

  • 1. Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).
    Annedi SC; Ramnauth J; Cossette M; Maddaford SP; Dove P; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2510-3. PubMed ID: 22370270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Annedi SC; Maddaford SP; Ramnauth J; Renton P; Speed J; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1980-4. PubMed ID: 22318159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.
    Annedi SC; Ramnauth J; Maddaford SP; Renton P; Rakhit S; Mladenova G; Dove P; Silverman S; Andrews JS; Felice MD; Porreca F
    J Med Chem; 2012 Jan; 55(2):943-55. PubMed ID: 22175766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
    Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.
    Annedi SC; Maddaford SP; Mladenova G; Ramnauth J; Rakhit S; Andrews JS; Lee DK; Zhang D; Porreca F; Bunton D; Christie L
    J Med Chem; 2011 Oct; 54(20):7408-16. PubMed ID: 21923116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.
    Mladenova G; Annedi SC; Ramnauth J; Maddaford SP; Rakhit S; Andrews JS; Zhang D; Porreca F
    J Med Chem; 2012 Apr; 55(7):3488-501. PubMed ID: 22420844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
    López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
    Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.
    Renton P; Speed J; Maddaford S; Annedi SC; Ramnauth J; Rakhit S; Andrews J
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5301-4. PubMed ID: 21813276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.
    López-Cara LC; Carrión MD; Entrena A; Gallo MA; Espinosa A; López A; Escames G; Acuña-Castroviejo D; Camacho ME
    Eur J Med Chem; 2012 Apr; 50():129-39. PubMed ID: 22336385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
    Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
    Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
    Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.
    Claramunt RM; López C; Pérez-Medina C; Pérez-Torralba M; Elguero J; Escames G; Acuña-Castroviejo D
    Bioorg Med Chem; 2009 Sep; 17(17):6180-7. PubMed ID: 19679481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
    Gómez-Vidal JA; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2004 Jan; 47(3):703-10. PubMed ID: 14736250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.
    Symons KT; Nguyen PM; Massari ME; Anzola JV; Staszewski LM; Wang L; Yazdani N; Dorow S; Muhammad J; Sablad M; Rozenkrants N; Bonefous C; Payne JE; Rix PJ; Shiau AK; Noble SA; Smith ND; Hassig CA; Zhang Y; Rao TS
    J Pharmacol Exp Ther; 2011 Feb; 336(2):468-78. PubMed ID: 21036913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.
    Ramnauth J; Renton P; Dove P; Annedi SC; Speed J; Silverman S; Mladenova G; Maddaford SP; Zinghini S; Rakhit S; Andrews J; Lee DK; Zhang D; Porreca F
    J Med Chem; 2012 Mar; 55(6):2882-93. PubMed ID: 22335555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
    Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
    Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
    Wei RG; Adler M; Davey D; Ho E; Mohan R; Polokoff M; Tseng JL; Whitlow M; Xu W; Yuan S; Phillips G
    Bioorg Med Chem Lett; 2007 May; 17(9):2499-504. PubMed ID: 17368901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice.
    Tanabe M; Nagatani Y; Saitoh K; Takasu K; Ono H
    Neuropharmacology; 2009 Mar; 56(3):702-8. PubMed ID: 19111753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
    J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.